(Press-News.org) Washington, DC – A compound called honokiol, which is found in the bark of multiple species of magnolia tree, inhibits replication of SARS-CoV-2 virus in several types of cells, according to a team of researchers in the Netherlands. The research is published in Microbiology Spectrum, a journal of the American Society for Microbiology.
The researchers found that Honokiol inhibits replication of SARS-CoV-2 in several cell types, causing production of infectious SARS-CoV-2 particles in treated cells to fall to around 1,000th of the previous level.
The compound also inhibited replication of other highly pathogenic human coronaviruses, including MERS- and SARS-CoV. “This suggests that it has a broad spectrum of activity and would likely also inhibit novel coronaviruses that might emerge in the future,” said Martijn J. van Hemert, Ph.D., Associate Professor, Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
The motivation for the research was the lack of vaccines and treatments early in the pandemic, and the desire to be prepared for the next new coronavirus. To this end, van Hemert emphasized that his group, as well as others from around the world, responded to COVID-19 by testing many compounds for antiviral effects.
“If honokiol can be developed into a drug, possibly in combination with other compounds, stockpiling it would help us to increase our preparedness for the emergence of the next coronavirus,” said van Hemert. “Broad-spectrum drugs could then be used to treat early patients and prevent spread, or they could be used prophylactically among healthcare workers, and in high-risk groups, such as among nursing home residents.”
Honokiol also has anti-inflammatory properties, van Hemert noted. That, he said, could be helpful in cases where patients wait until a relatively late stage of the disease to obtain medical treatment—a frequent occurrence—by which time the body’s own inflammatory responses to the infection are causing symptoms. “At that point, inhibition of virus replication might no longer be helpful, but honokiol’s anti-inflammatory response might mitigate the illness,” van Hemert explained.
Honokiol inhibits a later step of the viral replication cycle—one that takes place after the virus has entered the cell. The investigators suspect that honokiol does so by triggering processes in the host cell that impede replication of the virus. It did so in the case of the original SARS-CoV-2 variants, and also in that of the more recent omicron variants.
At this early stage in the research, “Our study merely provides the basis for further research into potential therapeutic applications,” said van Hemert. “It is important to mention that it is too early to claim that honokiol might be used in SARS-CoV-2 patients. This requires much more research and—if successful—properly conducted clinical trials.”
Van Hemert learned about honokiol from Jack Arbiser, M.D., Ph.D., of Emory School of Medicine, during the early stages of the pandemic. Arbiser had been researching honokiol’s anticancer properties, and he told van Hemert he thought that the effects of the compound on the host cell might be beneficial for treatment of COVID-19 patients as well.
Clarisse Salgado-Benvindo, a Ph.D. student in van Hemert’s group, performed most of the experiments, using cultured cells that the researchers infected with SARS-CoV-2, or the highly pathogenic coronaviruses SARS-CoV and MERS-CoV. Experimenters worked inside a BSL-3 lab, which is a special high containment lab, while wearing protective suits with full-face masks to prevent infection.
###
The American Society for Microbiology is one of the largest professional societies dedicated to the life sciences and is composed of 30,000 scientists and health practitioners. ASM's mission is to promote and advance the microbial sciences.
ASM advances the microbial sciences through conferences, publications, certifications, educational opportunities and advocacy efforts. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, ASM promotes a deeper understanding of the microbial sciences to diverse audiences.
END
Compound from magnolia tree bark impedes SARS-CoV-2 replication in certain cells
2023-05-22
ELSE PRESS RELEASES FROM THIS DATE:
Leadless pacemakers soon available for all patients
2023-05-22
Every year more than one million people receive a pacemaker. Until now, leadless versions were only available for 20% of these patients. However, thanks to an international consortium led by Amsterdam UMC, an improved version will soon be available for all patients. The results of this clinical trial are, today, published in the New England Journal of Medicine.
Research from Amsterdam UMC has succeeded in further revolutionising the wireless pacemaker. The improved version can now be placed in both the atrium and the ventricle of ...
Siblings with autism share more of dad’s genome, not mom’s
2023-05-22
Cold Spring Harbor Laboratory (CSHL) researchers have flipped the script on autism spectrum disorder (ASD) genetics.
Scientists long thought that siblings born with ASD share more of their mother’s genome than their father’s. But CSHL Associate Professor Ivan Iossifov and Professor Michael Wigler have now shown that, in many cases, it’s dad who might be playing a bigger genetic role.
Autism spectrum disorders cover a range of neurological and developmental conditions. They can affect how a person communicates, socializes, learns, and behaves. ASD may also manifest as repetitive behaviors ...
Women more likely to die after heart attack than men
2023-05-22
Prague, Czechia – 22 May 2023: Women are more than twice as likely to die after a heart attack than men, according to research presented today at Heart Failure 2023, a scientific congress of the European Society of Cardiology (ESC).1
“Women of all ages who experience a myocardial infarction are at particularly high risk of a poor prognosis,” said study author Dr. Mariana Martinho of Hospital Garcia de Orta, Almada, Portugal. “These women need regular monitoring after their heart event, with strict control of blood pressure, ...
ASCO: Targeted therapy for early breast cancer, progress treating recurrent glioma, PSMA PET scan advances and more
2023-05-22
Physicians and scientists from the UCLA Jonsson Comprehensive Cancer Center will discuss the latest research and clinical trial results on combination therapies for breast cancer, a potential new treatment for patients with recurrent glioma, and advances in PSMA PET guided radiotherapy for patients with prostate cancer, among other topics, at the American Society of Clinical Oncology’s annual meeting.
At this year’s scientific forum, Dr. Dennis Slamon, chair of hematology-oncology and director of clinical ...
Cancer researchers join forces against deadliest brain tumors in children
2023-05-22
Virginia Tech researchers with the Fralin Biomedical Research Institute at VTC have joined a Children’s National Hospital effort to treat deadly brain tumors with ultrahigh frequency sound waves.
The scientists are studying how to use an emerging technology called focused ultrasound to fight diffuse midline glioma (DMG), one of the most lethal childhood brain cancers with a nearly 100 percent rate of mortality within five years of diagnosis.
A multi-institutional team led by Javad Nazarian, a principal investigator with Children’s National Hospital, will study how to use focused ultrasound to create ...
Eruption of Tonga underwater volcano found to disrupt satellite signals halfway around the world
2023-05-22
An international team has used satellite- and ground-based ionospheric observations to demonstrate that an air pressure wave triggered by volcanic eruptions could produce an equatorial plasma bubble (EPB) in the ionosphere, severely disrupting satellite-based communications. Their findings were published in the journal Scientific Reports.
The ionosphere is the region of the Earth's upper atmosphere where molecules and atoms are ionized by solar radiation, creating positively charged ions. The area with the highest concentration of ionized particles is called the F-region, an area 150 to 800 km above the Earth's surface. The F-region plays ...
Adverse pregnancy outcomes increase stroke risk
2023-05-22
Investigators from the Smidt Heart Institute at Cedars-Sinai found that women who experience an adverse pregnancy outcome—such as gestational hypertension, preeclampsia or preterm birth—have a higher risk of developing stroke in their lifetime, and at a younger age.
The findings, published today in the peer-reviewed journal Stroke, also found that compared to women with one uncomplicated pregnancy, a woman who had two or more pregnancies impacted by an adverse pregnancy outcome had a twofold higher increase of stroke.
“We understand from past studies in the U.S. that women have a greater risk of experiencing a stroke and a disproportionate ...
Earlier snowpack melt in the West could bring summer water scarcity
2023-05-22
Snow is melting earlier, and more rain is falling instead of snow in the mountain ranges of the Western U.S. and Canada, leading to a leaner snowpack that could impact agriculture, wildfire risk and municipal water supplies come summer, according to a new study from the University of Colorado Boulder.
Published in Nature Communications Earth & Environment, the study documents more than 60 years of change in snowpack water storage across Western North America. It found that from 1950 to 2013, snowpack water storage ...
What’s the relationship between cancer survivors’ tobacco use, symptom burden, and motivation to quit smoking?
2023-05-22
Study’s findings may help inform tobacco cessation support efforts.
In a recent study, current smoking and vaping were associated with a higher burden of symptoms among adult cancer survivors, but these symptoms were not related to survivors’ desire to quit smoking. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
Continued smoking after a cancer diagnosis lowers survival rates, increases the likelihood of additional cancers, and decreases the effectiveness ...
Tokyo Tech, Tohoku University, Fujitsu, and RIKEN start collaboration to develop distributed training of Large Language Models
2023-05-22
Tokyo Institute of Technology (Tokyo Tech), Tohoku University, Fujitsu Limited, and RIKEN today announced that they will embark on the research and development of a distributed training of Large Language Models (LLM) [1]on supercomputer Fugaku in May 2023, within the scope of the initiatives for use of Fugaku defined by Japanese policy.
LLMs are AI models for deep learning that serve as the core of generative AI including ChatGPT[2]. The four organizations aim to improve the environment for creating LLMs that can be widely used by academia and companies, contribute to improving the research capabilities of AI in Japan, and increase the value of utilizing Fugaku in both ...